Delivery Order SPE2DB22D2214-SPE2DB25FS5DW
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a ceiling value of $1,464.99 and a completion date of May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,622.71, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML medical products. The firm-fixed-price contract has a ceiling value of $11,517.13 and a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,901.66, is for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a ceiling value of $1,382.31 and runs through September 9, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a prescription medication. The contract has a ceiling value of $2,153.78 and a completion date of May 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,079.54, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this award is March 17, 2025. This contract award is not designated as a set-aside....
This contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product. The delivery order is valued at $1,544.06 and has a period of performance through January 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,774.92 firm fixed-price delivery order is for the OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceutical product. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,885.73 firm fixed-price delivery order is for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty medication, to support military treatment programs and facilities. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...